Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients
Status:
Unknown status
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
This study compare the effects on microalbuminuria improvement in type 2 diabetes mellitus
(T2DM) treated with saxagliptin or glimepiride.All patients received metformin and/or
acarbose, and randomly receive saxagliptin (5mg/d) or glimepiride (1-4mg/d).